ID

21500

Description

Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00372905

Lien

https://clinicaltrials.gov/show/NCT00372905

Mots-clés

Versions (1)
  1. 25/04/2017 25/04/2017 -
Téléchargé le

25 avril 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Lymphoma NCT00372905

Anglais

Eligibility Lymphoma NCT00372905

1 Formulaires  
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00372905
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed follicular lymphoma
Description

Lymphoma, Follicular

Type de données

boolean

Alias
UMLS CUI [1]
C0024301
cd20+ at time of diagnosis or subsequently
Description

CD20 antigen positive

Type de données

boolean

Alias
UMLS CUI [1]
C3888518
more than 4 weeks since prior rituximab
Description

rituximab

Type de données

boolean

Alias
UMLS CUI [1]
C0393022
more than 3 weeks since prior anticancer therapy (6 weeks for nitrosourea or mitomycin c)
Description

cancer treatment | Nitrosourea | Mitomycin-c

Type de données

boolean

Alias
UMLS CUI [1]
C0920425
UMLS CUI [2]
C0028210
UMLS CUI [3]
C0002475
more than 4 weeks since prior major surgery
Description

major surgery

Type de données

boolean

Alias
UMLS CUI [1]
C0679637
more than 2 weeks since prior investigational drugs
Description

Investigational New Drugs

Type de données

boolean

Alias
UMLS CUI [1]
C0013230
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
aids-related lymphoma
Description

Lymphoma, AIDS-Related

Type de données

boolean

Alias
UMLS CUI [1]
C0085090
history or evidence of cns involvement
Description

Central Nervous System Involvement | Central Nervous System Involvement Evidence of

Type de données

boolean

Alias
UMLS CUI [1]
C4050309
UMLS CUI [2,1]
C4050309
UMLS CUI [2,2]
C0332120
pregnant or nursing
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
known hiv positivity
Description

HIV Seropositivity

Type de données

boolean

Alias
UMLS CUI [1]
C0019699
serious medical or psychiatric illness that would preclude study participation
Description

Illness Serious Study Subject Participation Status Exclusion | Mental disorder Serious Study Subject Participation Status Exclusion

Type de données

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C2348568
UMLS CUI [1,4]
C2828389
UMLS CUI [2,1]
C0004936
UMLS CUI [2,2]
C0205404
UMLS CUI [2,3]
C2348568
UMLS CUI [2,4]
C2828389
myocardial infarction within the past 6 months
Description

Myocardial Infarction

Type de données

boolean

Alias
UMLS CUI [1]
C0027051
congestive heart failure, uncontrolled angina, severe uncontrolled ventricular arrhythmias, or ecg evidence of acute ischemia or active conduction system abnormalities
Description

Congestive heart failure | Angina control - poor | Ventricular arrhythmia Severe Uncontrolled | Acute myocardial ischemia Evidence Electrocardiography | Conduction system abnormalities

Type de données

boolean

Alias
UMLS CUI [1]
C0018802
UMLS CUI [2]
C0421196
UMLS CUI [3,1]
C0085612
UMLS CUI [3,2]
C0205082
UMLS CUI [3,3]
C0205318
UMLS CUI [4,1]
C0746731
UMLS CUI [4,2]
C3887511
UMLS CUI [4,3]
C1623258
UMLS CUI [5]
C0151236
known hypersensitivity to rituximab, bortezomib, boron, or mannitol
Description

Hypersensitivity rituximab | Hypersensitivity bortezomib | Hypersensitivity Boron | Hypersensitivity Mannitol

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0393022
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C1176309
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0006030
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0024730
prior autologous or allogeneic stem cell transplantation
Description

Transplantation of autologous hematopoietic stem cell | Allogeneic Hematopoietic Stem Cell Transplantation

Type de données

boolean

Alias
UMLS CUI [1]
C1831743
UMLS CUI [2]
C1705576
prior radioimmunoconjugate therapy or prior exposure to murine antibodies
Description

Radioimmunoconjugates | Murine-Derived Monoclonal Antibodies Exposure to

Type de données

boolean

Alias
UMLS CUI [1]
C0243019
UMLS CUI [2,1]
C2916903
UMLS CUI [2,2]
C0332157
prior external-beam irradiation to > 25% of active bone marrow
Description

Teleradiotherapy Bone Marrow Percentage

Type de données

boolean

Alias
UMLS CUI [1,1]
C0419095
UMLS CUI [1,2]
C0005953
UMLS CUI [1,3]
C0439165
Retour au début de la page

Similar models

Eligibility Lymphoma NCT00372905

1 Formulaires
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00372905
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Lymphoma, Follicular
Item
histologically confirmed follicular lymphoma
boolean
C0024301 (UMLS CUI [1])
CD20 antigen positive
Item
cd20+ at time of diagnosis or subsequently
boolean
C3888518 (UMLS CUI [1])
rituximab
Item
more than 4 weeks since prior rituximab
boolean
C0393022 (UMLS CUI [1])
cancer treatment | Nitrosourea | Mitomycin-c
Item
more than 3 weeks since prior anticancer therapy (6 weeks for nitrosourea or mitomycin c)
boolean
C0920425 (UMLS CUI [1])
C0028210 (UMLS CUI [2])
C0002475 (UMLS CUI [3])
major surgery
Item
more than 4 weeks since prior major surgery
boolean
C0679637 (UMLS CUI [1])
Investigational New Drugs
Item
more than 2 weeks since prior investigational drugs
boolean
C0013230 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Lymphoma, AIDS-Related
Item
aids-related lymphoma
boolean
C0085090 (UMLS CUI [1])
Central Nervous System Involvement | Central Nervous System Involvement Evidence of
Item
history or evidence of cns involvement
boolean
C4050309 (UMLS CUI [1])
C4050309 (UMLS CUI [2,1])
C0332120 (UMLS CUI [2,2])
Pregnancy | Breast Feeding
Item
pregnant or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
HIV Seropositivity
Item
known hiv positivity
boolean
C0019699 (UMLS CUI [1])
Illness Serious Study Subject Participation Status Exclusion | Mental disorder Serious Study Subject Participation Status Exclusion
Item
serious medical or psychiatric illness that would preclude study participation
boolean
C0221423 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C2828389 (UMLS CUI [1,4])
C0004936 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C2348568 (UMLS CUI [2,3])
C2828389 (UMLS CUI [2,4])
Myocardial Infarction
Item
myocardial infarction within the past 6 months
boolean
C0027051 (UMLS CUI [1])
Congestive heart failure | Angina control - poor | Ventricular arrhythmia Severe Uncontrolled | Acute myocardial ischemia Evidence Electrocardiography | Conduction system abnormalities
Item
congestive heart failure, uncontrolled angina, severe uncontrolled ventricular arrhythmias, or ecg evidence of acute ischemia or active conduction system abnormalities
boolean
C0018802 (UMLS CUI [1])
C0421196 (UMLS CUI [2])
C0085612 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0205318 (UMLS CUI [3,3])
C0746731 (UMLS CUI [4,1])
C3887511 (UMLS CUI [4,2])
C1623258 (UMLS CUI [4,3])
C0151236 (UMLS CUI [5])
Hypersensitivity rituximab | Hypersensitivity bortezomib | Hypersensitivity Boron | Hypersensitivity Mannitol
Item
known hypersensitivity to rituximab, bortezomib, boron, or mannitol
boolean
C0020517 (UMLS CUI [1,1])
C0393022 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C1176309 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0006030 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0024730 (UMLS CUI [4,2])
Transplantation of autologous hematopoietic stem cell | Allogeneic Hematopoietic Stem Cell Transplantation
Item
prior autologous or allogeneic stem cell transplantation
boolean
C1831743 (UMLS CUI [1])
C1705576 (UMLS CUI [2])
Radioimmunoconjugates | Murine-Derived Monoclonal Antibodies Exposure to
Item
prior radioimmunoconjugate therapy or prior exposure to murine antibodies
boolean
C0243019 (UMLS CUI [1])
C2916903 (UMLS CUI [2,1])
C0332157 (UMLS CUI [2,2])
Teleradiotherapy Bone Marrow Percentage
Item
prior external-beam irradiation to > 25% of active bone marrow
boolean
C0419095 (UMLS CUI [1,1])
C0005953 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial